EP Patent

EP1406605B1 — Carbamates of 2-heterocyclic-1,2-ethanediols

Assigned to SK Inc · Expires 2007-09-19 · 19y expired

What this patent protects

Carbamate compounds of 2-heteroaryl-1,2-ethanediol are described. The compounds are effective in the treatment of disorders of the central nervous system, especially as anti-convulsive or anti-epileptic agents.

USPTO Abstract

Carbamate compounds of 2-heteroaryl-1,2-ethanediol are described. The compounds are effective in the treatment of disorders of the central nervous system, especially as anti-convulsive or anti-epileptic agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP1406605B1
Jurisdiction
EP
Classification
—
Expires
2007-09-19
Drug substance claim
No
Drug product claim
No
Assignee
SK Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.